Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05633511 · ClinicalTrials.gov registry record · NA
Changes of Soft Tissue Grafting: A Randomized Study
A NA study of Gingival Recession, sponsored by Tufts University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05633511: Recruiting NA study of Gingival Recession, sponsored by Tufts University.
NCT05633511 is a NA study of Gingival Recession that is actively recruiting participants, run by Tufts University. The registered enrollment target is 50 participants, above the 29-participant average among 10 other Gingival Recession trials with a reported enrollment target (72% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05633511, a NA study of Gingival Recession, is actively recruiting participants, sponsored by Tufts University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
To correct gum recession, patient's own tissue from the roof of the mouth is harvested and placed where there is root exposed. This is considered gold standard of treatment. Sometimes patient don't want to have second surgical site in their mouth and at the same time do not want to use alternative tissue from human or animal donor. Using patients' blood and preparing it as a membrane is the next best thing to correct gum recession.
Primary Outcome
Primary objective of this study is to compare in a split-mouth study the effectiveness of CTG vs. PRF in soft tissue augmentation and volume stability of each treatment modality in correcting the Cairo Class I, II defects in Periodontally affected patients
Conditions Studied
Interventions
- PROCEDURE Split Mouth Design
Study Locations (1)
Massachusetts
- Tufts University School of Dental Medicine - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-01-11 |
| Est. Completion | 2036-12-30 |
| Phase | NA |
What NCT05633511 shows while recruiting
NCT05633511 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, above the 29-participant average among 10 other Gingival Recession trials with a reported enrollment target (72% higher).
The record links to 1 condition, with Gingival Recession appearing as the primary indexed condition, and to 1 intervention - of which Split Mouth Design is the first listed.
NCT05633511 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05633511 about?
NCT05633511 is a clinical study titled "Changes of Soft Tissue Grafting: A Randomized Study". To correct gum recession, patient's own tissue from the roof of the mouth is harvested and placed where there is root exposed. This is considered gold standard of treatment. Sometimes patient don't want to have second surgical site in their mouth and at the same time do not want to use alternative t...
What is the current status of trial NCT05633511?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-01-11. Estimated completion is 2036-12-30.
What conditions does trial NCT05633511 study?
This clinical trial studies the following conditions: Gingival Recession.
What interventions are being tested in trial NCT05633511?
The interventions under investigation include: Split Mouth Design (PROCEDURE).
Who is sponsoring clinical trial NCT05633511?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05633511 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gingival Recession
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05633511's enrollment target sits among peer trials
50 1st of 10 higher than 10 of 10 other Gingival Recession trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gingival Recession trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gain of Keratinized Mucosa Around Teeth and Dental Implants Using a Combination of Strip Gingival Graft and Acellular Dermal Matrix
RECRUITING · NA
-
Patient-reported Outcomes of Donor Site Healing Using Different Palatal Protection Techniques
RECRUITING · NA
-
A Comparison of Side Access Mucosal Releasing Incision (SAMRI) and Sulcular Tunnel Access to Treat Gingival Recession.
ACTIVE NOT RECRUITING · NA
-
Thick vs. Thin Acellular Dermal Matrix (ADM)
COMPLETED · NA
-
Evaluation of Geistlich Fibro-Gide® + CAF in Comparison to CTG + CAF for the Treatment of Recession Defects at 6 Months
COMPLETED · NA
-
Treatment of Gingival Recession Defects Using Platelet-Rich Fibrin With an Allogenic Dermal Matrix
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI